XtalPi, an AI drug discovery company based in Hong Kong, has announced its first full-year profit, reporting RMB 258 million (USD 36 million). This financial milestone was achieved on RMB 800 million (USD 112 million) in revenue, largely attributed to a significant contract with a US pharmaceutical company. The firm also disclosed substantial cash reserves, holding over RMB 7 billion (USD 980 million). AI
影响 Demonstrates AI's increasing viability in specialized sectors like drug discovery, potentially signaling a new trend for AI-driven biotech profitability.
排序理由 AI company reports first full-year profit and significant cash reserves.
在 Mastodon — fosstodon.org 阅读 →
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
